月经过多时子宫内膜血管发育:内皮细胞标志物和细胞外基质组分的时空表达改变
研究比较健康女性与月经过多(HMB)女性子宫内膜及浅肌层血管在月经周期中的表型与结构变化,采用免疫组化半定量评估内皮细胞标志物和细胞外基质蛋白。结果显示健康女性这些蛋白随周期呈动态表达,而HMB女性表达改变,尤其在分泌期宫腔区和功能层。作者认为HMB症状可能与血管结构较弱相关,尤其在月经周期晚分泌期。
要点
- 健康女性子宫内膜和肌层血管的四种内皮细胞标志物随月经周期呈动态表达。
- HMB女性分泌期宫腔区和功能层内皮标志物表达改变,晚分泌期UEA-1和CD31降低而F8RA和CD34升高。
- HMB女性细胞外基质蛋白表达改变,晚分泌期功能层骨桥蛋白升高,中分泌期基底层和早分泌期功能层胶原IV降低。
核心结论
- HMB症状可能与血管结构较弱相关,尤其在月经周期晚分泌期,可能导致月经期血流增加和延长。
研究设计与样本
- 从子宫切除标本取含子宫内膜和浅肌层的活检组织,健康对照和无子宫内膜病理的主观HMB女性各月经周期阶段(增殖期、早分泌期、中分泌期、晚分泌期)N=5。
- 组织经福尔马林固定石蜡包埋,连续切片免疫染色内皮细胞标志物、细胞外基质标志物和Ki67,半定量评分血管免疫反应性。
主要发现
- 对照样本中四种内皮细胞标志物在子宫内膜和肌层血管均随月经周期呈动态表达。
- 晚分泌期宫腔区UEA-1和CD31在HMB组平均Quickscore分别为1和5,低于对照组的3.2和7.4(均P=0.008)。
- 晚分泌期宫腔区F8RA和CD34在HMB组分别为1.4和8,高于对照组的0和5.8(均P=0.008)。
- 晚分泌期功能层骨桥蛋白在HMB组为11.2,高于对照组的7.2(P=0.008)。
- 中分泌期基底层胶原IV在HMB组为2.8,低于对照组的4.6(P=0.002);早分泌期功能层胶原IV在HMB组为3.2,低于对照组的7(P=0.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 血管内皮细胞标志物和细胞外基质蛋白的表达采用半定量方法评估,涵盖直小动脉和螺旋小动脉。
- 本研究中HMB由主观标准判定,未评估失血量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are there any phenotypic and structural/architectural changes in the vessels of endometrium and superficial myometrium during the normal menstrual cycle in healthy women and those with heavy menstrual bleeding (HMB)? SUMMARY ANSWER: Spatial and temporal differences in protein levels of endothelial cell (EC) markers and components of the extracellular matrix (ECM) were detected across the menstrual cycle in healthy women and these are altered in HMB. WHAT IS KNOWN ALREADY: HMB affects 30% of women of reproductive age with ~50% of cases being idiopathic. We have previously shown that the differentiation status of endometrial vascular smooth muscle cells (VSMCs) is altered in women with HMB, suggesting altered vessel maturation compared to controls. Endometrial arteriogenesis requires the co-ordinated maturation not only of the VSMCs but also the underlying ECs and surrounding ECM. We hypothesized that there are spatial and temporal patterns of protein expression of EC markers and vascular ECM components in the endometrium across the menstrual cycle, which are altered in women with HMB. STUDY DESIGN, SIZE, DURATION: Biopsies containing endometrium and superficial myometrium were taken from hysterectomy specimens from both healthy control women without endometrial pathology and women with subjective HMB in the proliferative (PP), early secretory (ESP), mid secretory (MSP) and late secretory (LSP) phases (N = 5 for each cycle phase and subject group). Samples were fixed in formalin and embedded in paraffin wax. PARTICIPANTS/MATERIALS, SETTING, METHODS: Serial sections (3μm thick) were immunostained for EC markers (factor VIII related antigen (F8RA), CD34, CD31 and ulex europaeus-agglutinin I (UEA-1) lectin), structural ECM markers (osteopontin, laminin, fibronectin and collagen IV) and for Ki67 to assess proliferation. Immunoreactivity of vessels in superficial myometrium, endometrial stratum basalis, stratum functionalis and luminal region was scored using either a modified Quickscore or by counting the number of positive vessels. MAIN RESULTS AND THE ROLE OF CHANCE: In control samples, all four EC markers showed a dynamic expression pattern according to the menstrual cycle phase, in both endometrial and myometrial vessels. EC protein marker expression was altered in women with HMB compared with controls, especially in the secretory phase in the endometrial luminal region and stratum functionalis. For example, in the LSP expression of UEA-1 and CD31 in the luminal region decreased in HMB (mean quickscore: 1 and 5, respectively) compared with controls (3.2 and 7.4, respectively) (both P = 0.008), while expression of F8RA and CD34 increased in HMB (1.4 and 8, respectively) compared with controls (0 and 5.8, respectively) (both P = 0.008). There was also a distinct pattern of expression of the vascular structural ECM protein components osteopontin, laminin, fibronectin and collagen IV in the superficial myometrium, stratum functionalis and stratum basalis during the menstrual cycle, which was altered in HMB. In particular, compared with controls, osteopontin expression in HMB was higher in stratum functionalis in the LSP (7.2 and 11.2, respectively P = 0.008), while collagen IV expression was reduced in stratum basalis in the MSP (4.6 and 2.8, respectively P = 0.002) and in stratum functionalis in the ESP (7 and 3.2, respectively P = 0.008). LIMITATIONS, REASONS FOR CAUTION: The protein expression of vascular EC markers and ECM components was assessed using a semi-quantitative approach in both straight and spiral arterioles. In our hospital, HMB is determined by subjective criteria and levels of blood loss were not assessed. WIDER IMPLICATIONS OF THE FINDINGS: Variation in the protein expression pattern between the four EC markers highlights the importance of choice of EC marker for investigation of endometrial vessels. Differences in expression of the different EC markers may reflect developmental stage dependent expression of EC markers in endometrial vessels, and their altered expression in HMB may reflect dysregulated vascular development. This hypothesis is supported by altered expression of ECM proteins within endometrial vessel walls, as well as our previous data showing a dysregulation in VSMC contractile protein expression in the endometrium of women with HMB. Taken together, these data support the suggestion that HMB symptoms are associated with weaker vascular structures, particularly in the LSP of the menstrual cycle, which may lead to increased and extended blood flow during menstruation. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by Wellbeing of Women (RG1342) and Newcastle University. There are no competing interests to declare. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Biswas Shivhare S, Bulmer JN, Innes BA, et al. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components. Hum Reprod. 2018. PMID: 29309596. doi:10.1093/humrep/dex378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。